Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Carrier-priming leads to hapten-specific suppression.

× No keyword cloud information.

46 in total

Review 1. Carbohydrate-based cancer vaccines: target cancer with sugar bullets.

Authors: Chang-Cheng Liu; Xin-Shan Ye
Journal: Glycoconj J Date: 2012-06-06 Impact factor: 2.916

2. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.

Authors: C Gravekamp; D L Kasper; L C Paoletti; L C Madoff
Journal: Infect Immun Date: 1999-05 Impact factor: 3.441

3. Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine.

Authors: T Barington; K Kristensen; J Henrichsen; C Heilmann
Journal: Infect Immun Date: 1991-03 Impact factor: 3.441

4. Antibodies to Mycobacterium tuberculosis-specific epitopes in lepromatous leprosy.

Authors: G Bothamley; J S Beck; W Britton; A Elsaghier; J Ivanyi
Journal: Clin Exp Immunol Date: 1991-12 Impact factor: 4.330

5. Immune responses in congenic mice to multiple antigen peptides based on defined epitopes from the malaria antigen Pf332.

Authors: N Ahlborg; R Andersson; P Perlmann; K Berzins
Journal: Immunology Date: 1996-08 Impact factor: 7.397

6. A dual vaccine against influenza & Alzheimer's disease failed to enhance anti-β-amyloid antibody responses in mice with pre-existing virus specific memory.

Authors: Hayk Davtyan; Anahit Ghochikyan; Armine Hovakimyan; Arpine Davtyan; Richard Cadagan; Annette M Marleau; Randy A Albrecht; Adolfo García-Sastre; Michael G Agadjanyan
Journal: J Neuroimmunol Date: 2014-10-16 Impact factor: 3.478

7. Visualization of negative signaling in B cells by quantitative confocal microscopy.

Authors: H Phee; W Rodgers; K M Coggeshall
Journal: Mol Cell Biol Date: 2001-12 Impact factor: 4.272

Review 8. Clustered carbohydrates in synthetic vaccines.

Authors: Francesco Peri
Journal: Chem Soc Rev Date: 2012-12-18 Impact factor: 54.564

9. Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses.

Authors: Francesco Forconi; Catherine A King; Surinder S Sahota; Christopher K Kennaway; Nigel H Russell; Freda K Stevenson
Journal: Immunology Date: 2002-09 Impact factor: 7.397

10. Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man.

Authors: M R Downham; T R Auton; A Rosul; H L Sharp; L Sjöström; A Rushton; J P Richards; T G K Mant; S M Gardiner; T Bennett; J F Glover
Journal: Br J Clin Pharmacol Date: 2003-11 Impact factor: 4.335